Conagen

[Not Yet Scheduled]
Conagen is advancing the ways natural products are manufactured with molecule-per-molecule precision and customization. We uncover the metabolic pathways of nature and engineer unique microbes by way of synthetic biology, and develop high-quality products through specialized fermentation. Our innovation is delivered to the food and beverage, flavor and fragrance, nutrition, renewable materials, and pharma markets.
Company Type:
Privately Funded Company
Company Website:
Company HQ State:
Massachusetts
Company HQ Country:
United States
Year Founded:
2010
Main Therapeutic Focus:
Lead Product in Development:
Trastuzumab biosimilar
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Speaker
photo
VP of R&D
Conagen